Optima breast study

Author: mzdu

August undefined, 2024

http://optimabreaststudy.com/ WebOptimal Personalised Treatment of early breast cancer using Multi-parameter Analysis. OPTIMA, led by principal investigator Professor Rob Stein, a consultant oncologist at University College London Hospitals NHS Foundation Trust is a partially-blind randomised trial designed to compare clinical and economic outcomes of standard chemotherapy …

Scientific summary - OPTIMA prelim: a randomised …

WebMar 1, 2024 · A study looking at radiotherapy for women with a very small risk of their breast cancer returning (PRIMETIME) Cancer Research UK This study is to see if women who only have a very small risk of their breast cancer … WebJun 11, 2014 · OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients (OPTIMA) The safety and … fitday classic

OPTIMA prelim: a randomised feasibility study of

WebOct 12, 2024 · OPTIMA aims to develop a secure platform to bring together data on prostate, breast and lung cancer held in EHRs and other real-world data sources from more than 200 million people, in order to support the delivery of patient care. WebJan 10, 2014 · Olaparib treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy Detailed Description: Patients will be randomised in 1:1 ratio to either olaparib or placebo. WebDec 23, 2024 · OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence) is a research project that wants to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence. As part of this project, researchers want to understand out what research questions in breast cancer … fitday enterprise company limited

OPTIMA: Optimal Personalised Treatment of early breast …

Optima breast study

WebWelcome to OPTIMA, a patient driven clinical study for people with hormone sensitive early breast cancer. OPTIMA aims to improve the way we make decisions about whom we … Taking Part in OPTIMA - OPTIMA OPTIMA Recruiting Sites - OPTIMA The OPTIMA Team - OPTIMA Study Team Contact Details. OPTIMA Trial Team - Warwick Clinical Trials Unit … OPTIMA Protocol v9.0 2024 09 17; OPTIMA Patient flyer v3.0 2024 08 11; OPTIMA … Newsletters - OPTIMA Please check the full eligibility criteria in the protocol to ensure potential participants … OPTIMA QRS Staff IS and CF V5.1 10 09 2024; OPTIMA QRS Documentation … OPTIMA Recruitment and Informed Consent Guidance v2.0 2024-03-28; OPTIMA … Publications - OPTIMA WebMay 28, 2024 · Methods: OPTIMA is an international academic, partially-blinded RCT of test-directed chemotherapy treatment with an adaptive design. Women and men aged 40 or …

Did you know?

WebApr 14, 2014 · Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) (OPTIMA) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. WebAug 4, 2024 · Data from OPTIMA, including Chemistry, Manufacturing, and Controls information, has been sent to the National Institutes of Health (NIH) to undergo independent analysis. Computed tomography scans...

WebFeb 15, 2024 · OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis) (ISRCTN42400492) is a prospective international randomised controlled trial (RCT) designed to... WebJan 21, 2009 · This is a research study to evaluate the effects of ThermoDox in combination with therapeutic heating of the chest wall in the treatment of recurrent regional breast cancer. The purpose of this study is to evaluate the bioequivalence of ThermoDox and measure efficacy in recurrent chest wall patients. Show detailed description Study Design …

WebThe OPTIMA prelim study sought to evaluate diagnostic tests in a high-risk patient group as defined by tumour stage; for some tests this means that results from the OPTIMA prelim are using risk scores designed for node … WebFeb 15, 2024 · OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis) (ISRCTN42400492) is a prospective international randomised controlled trial (RCT) designed to validate MPA’s as predictors of chemotherapy sensitivity in a largely node-positive breast cancer population. Methods: OPTIMA is a partially blinded …

WebThe Optimal Personalised Treatment of early breast cancer usIng Multiparameter Analysis preliminary study (OPTIMA prelim) (ISRCTN42400492) was the feasibility phase of a …

WebBreast cancer is a major public health problem. It is the most commonly occurring cancer in the UK, with an annual incidence of 50,000, and it is the second most frequent cause of cancer death in women, with about 12,000 deaths in 2011.1 Of the women who develop breast cancer, 80% are over 50 years old at diagnosis and most deaths occur in this age … fitday login problemsWebOPTIMA prelim included research with patient focus groups, and interviews of both staff and patients. This research provided insights into how patients feel about making informed decisions in breast cancer clinics, and how to improve the quality of information provided. can hamburger meat be pinkWebJul 9, 2024 · The OPTIMA Study is a global, randomized, double-blind, placebo-controlled clinical trial assessing the efficacy of ThermoDox ® in combination with RFA, which was standardized to a minimum of 45 minutes for treating patients with a lesion 3-7 cm in size, versus standardized RFA alone. can hamburger buns be refrozenWebFeb 24, 2024 · This issue may be elucidated with the ongoing OPTIMA study, where premenopausal women with breast cancer receive either chemotherapy followed by ET (tamoxifen or an aromatase inhibitor) or... fitday app for iphoneWebOPTIMA HEALTH INSURANCE COMPANY ... Breast Augmentation, Mastopexy, ... ¾ The drug, device, medical treatment or procedure is currently under study in a Phase I, Phase II clinical trial, an experimental study/investigational arm of a Phase III clinical study, or otherwise under study to determine safety and efficacy or to ... fit day imperioWebMar 24, 2024 · The OPTIMA study is a patient driven clinical study for people with hormone sensitive early breast cancer. OPTIMA aims to improve the way we make decisions about whom we offer... can hamburger meat be cooked in a crock potWebMay 20, 2016 · OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions. Andreas Makris , Luke Hughes-Davies , Iain R. MacPherson , Andrea Marshall , Amy F. Campbell , John … fit day opinie